Physician profile
Susan E Rice
NPI 1316649189
$1,474.81
in general payments reported to CMS, 2019-2025
16 companies · $997 in 2025
The $997 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $478 · 2025: $997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,474.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $507.42 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $260.61 | 2024-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $156.79 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Phathom Pharmaceuticals, INC. | $105.78 | 2024-2025 | Voquezna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.08 | 2024-2025 | Jardiance |
| Abbvie INC. | $61.58 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $60.85 | 2024-2025 | Gemtesa |
| Daiichi Sankyo INC. | $45.33 | 2024-2025 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $30.77 | 2024 | |
| Seqirus USA INC | $29.70 | 2025 | Flucelvax, Fluad |
| Amgen INC. | $28.61 | 2024 | Prolia, Evenity, Otezla |
| Heartflow, INC. | $24.16 | 2024 | |
| Daxor Corporation | $18.96 | 2024 | Bva-100 |
| Exact Sciences Corporation | $15.10 | 2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $14.66 | 2024 | Capvaxive |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $13.41 | 2024 | Keveyis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.